19 June 2013
Keywords: netherlands, oks, quadra, cancer, drug, logics, received
Article | 02 May 1994
Quadra Logics has received approval in the Netherlands to market its light activated Photofrin drug for the treatment of lung ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.